Perinatal bisphenol A exposure promotes hyperactivity, lean body composition, and hormonal responses across the murine life course by Anderson, Olivia S. et al.
The FASEB Journal • Research Communication
Perinatal bisphenol A exposure promotes hyperactivity,
lean body composition, and hormonal responses
across the murine life course
Olivia S. Anderson,* Karen E. Peterson,*,† Brisa N. Sanchez,‡ Zhenzhen Zhang,‡
Peter Mancuso,* and Dana C. Dolinoy*,1
*Department of Environmental Health Sciences, †Center for Human Growth and Development,
and ‡Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA
ABSTRACT The development of adult-onset diseases
is influenced by perinatal exposure to altered environ-
mental conditions. One such exposure, bisphenol A
(BPA), has been associated with obesity and diabetes,
and consequently labeled an obesogen. Using an iso-
genic murine model, we examined the effects of peri-
natal exposure through maternal diet to 50 ng (n20),
50 g (n21), or 50 mg (n18) BPA/kg diet, as well as
controls (n20) on offspring energy expenditure,
spontaneous activity, and body composition at 3, 6, and
9 mo of age, and hormone levels at 9 and 10 mo of age.
Overall, exposed females and males exhibited in-
creased energy expenditure (P<0.001 and 0.001, re-
spectively) throughout the life course. In females,
horizontal and vertical activity increased (P0.07 and
0.06, respectively) throughout the life course. Gener-
ally, body composition measures were not different
throughout the life course in exposed females or males
(all P>0.44), although body fat and weight decreased in
exposed females at particular ages (all P<0.08). Milli-
gram-exposed females had improved glucose, insulin,
adiponectin, and leptin profiles (all P<0.10). Thus,
life-course analysis illustrates that BPA is associated
with hyperactive and lean phenotypes. Variability across
studies may be attributable to differential exposure
duration and timing, dietary fat and phytoestrogen
content, or lack of sophisticated phenotyping across the
life course.—Anderson, O.S., Peterson, K.E., Sanchez,
B.N., Zhang, Z., Mancuso, P., Dolinoy, D.C. Perinatal
bisphenol A exposure promotes hyperactivity, lean
body composition, and hormonal responses across the
murine life course. FASEB J. 27, 1784–1792 (2013).
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Human exposure to bisphenol A (BPA), the mono-
mer comprising polycarbonate plastic and epoxy resin,
is widespread, and several studies have reported detect-
able levels of total urinary BPA in a majority of individ-
uals in populations around the world, including the
United States, China, and Korea (1, 2). BPA is pro-
duced in high volumes and found in consumer prod-
ucts, such as food and water containers, baby bottles,
receipt paper, dental composites, and metal can lin-
ings. BPA can leach from consumer products, which
presents many opportunities for human exposure, most
commonly via ingestion and, to a lesser extent, via
inhalation and dermal routes (3).
BPA can mimic or antagonize endogenous hormones
and subsequently perturb endocrine function (4, 5).
For example, BPA has a strong binding affinity for the
transmembrane estrogen receptor (ER), G-protein-cou-
pled receptor 30 (GPR30), and estrogen-related recep-
tor  (ERR) (6, 7). BPA can activate transcription
factors, such as peroxisome proliferator-activated re-
ceptors (PPARs) and the aryl hydrocarbon receptor
(AhR) (8, 9). BPA has been labeled an environmental
obesogen (10, 11), a xenobiotic chemical contributing
to obesity and related phenotypes, due to its ability to
interfere with the ERs  and  in adipose and pancre-
atic tissues and to exert antagonistic effects on the
thyroid hormone receptor (4, 12, 13). As these receptor
pathways play an important role in gene regulation,
BPA may influence normal differentiation and matura-
tion processes during embryonic and fetal develop-
ment, predisposing individuals to chronic disease, such
as obesity, throughout the life span (14, 15).
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Animal models of perinatal BPA exposure provide
insight into potential alterations this chemical elicits on
metabolic homeostasis (11, 16). Male offspring devel-
oped insulin resistance and glucose intolerance as
adults when exposed to 10 g BPA/kg body weight
(BW) from gestational day (GD) 9 to GD 16 (17). In
utero BPA exposure was associated with overexpression
of lipogenic genes in rats, resulting in enhanced adipo-
genesis of white adipose tissue measured at postnatal
day (PND) 21 (18). In human adipose tissue explants,
BPA inhibited the release of adiponectin and stimu-
lated production of cytokines interleukin-6 and tumor
necrosis factor , common proinflammatory markers
found in overweight/obese individuals (19). In human
epidemiological studies, Lang et al. (20) found a posi-
tive association between adult BPA urinary levels and
type 2 diabetes and cardiovascular disease, and recent
data correlated BPA levels and obesity in children (21).
Collectively, this work suggests that BPA may be a
contributing factor to the obesity epidemic (22).
Despite the increasing evidence describing BPA as an
obesogen, another proposed target of BPA involves im-
pairment of central nervous system (CNS) development
(23). Animal studies revealed that perinatal BPA exposure
was positively associated with spontaneous activity, aggres-
sion, and altered cognitive function (24, 25). Zhou et al.
(26) reported that perinatal BPA exposure was associated
with hyperactivity and decreased attention mediated by
dopaminergic enhancement. Further animal models
demonstrated that BPA targets the CNS in early develop-
ment (27) and resulting behavioral outcomes correlated
to human clinical disorders such as attention-deficit and
hyperactivity disorder (ADHD) and aggression. These
human clinical disorders have also been found to be
associated with maternal BPA exposure in human epide-
miological studies (26, 28).
Considering the evidence from animal and human
models of altered health outcomes resulting from early
life BPA exposure, the aim of the present study was to
assess the effects of in utero and early postnatal exposure to
multiple physiologically relevant BPA levels on spontane-
ous activity, energy expenditure, body composition, and
hormones/adipokines by incorporating sophisticated an-
imal phenotyping at three time-points throughout the
murine life course. Herein we report increased energy
expenditure and spontaneous activity, decreased body
weight and fat, and altered hormonal parameters across
BPA-exposed offspring. Effects were most prevalent and
observed across all doses in female offspring. Males also
exhibited effects, although they were not consistently
observed across all outcomes and exposure groups.
MATERIALS AND METHODS
Animals and diets
Mice were obtained from a colony that has been maintained
with sibling mating and forced heterozygosity for the viable
yellow agouti (Avy) allele for 220 generations, resulting in a
genetically invariant background (29). Virgin wild-type a/a
dams, 6 wk of age, were randomly assigned to one of 4
phytoestrogen-free AIN-93G diets (diet 95092 with 7% corn
oil substituted for 7% soybean oil; Harlan Teklad, Madison,
WI, USA): standard diet (n11 litters); standard diet supple-
mented with 50 ng BPA/kg diet (n14 litters); standard diet
supplemented with 50 g BPA/kg diet (n9 litters); or
standard diet supplemented with 50 mg BPA/kg diet (n13
litters). All diet ingredients were supplied by Harlan Teklad
except BPA, which was supplied by the National Toxicology
Program (NTP; Durham, NC, USA). The milligram dosage is
an order of magnitude lower than the dietary administered
maximum nontoxic threshold in rodents (200 mg/kg BW/d;
ref. 30), but it is important to note, as previously reported, all
three BPA dosages capture human physiologically relevant
exposure (31, 32).
Wild-type a/a dams were provided with their respective diet
2 wk prior to mating with 8-wk-old Avy/a males and housed in
polycarbonate-free cages with ad libitum access to diet and
BPA-free water. The dams remained on the assigned diets
throughout pregnancy and lactation, after which offspring
were weaned and fed the standard phytoestrogen-free control
diet. This mating scheme produces 50% a/a genotype
offspring and 50% Avy/a offspring. At PND 22, offspring were
weighed and changed to the corn oil control diet. For this
study, a subset of a/a wild-type animals, representing1 male
and 1 female/litter, was followed until 10 mo of age: standard
diet (n20 offspring); 50 ng BPA/kg diet (n20 offspring);
50 g BPA/kg diet (n21 offspring); or 50 mg BPA/kg diet
(n18 offspring). Animals used in this study were maintained
in accordance with the Institute of Laboratory Animal Re-
sources guidelines (33) and were treated humanely and with
regard for alleviation of suffering. The study protocol was
approved by the University of Michigan Committee on Use
and Care of Animals.
Life-course evaluation
Only wild-type a/a offspring were followed for life-course
animal phenotyping to exclude bias from metabolic distur-
bance induced by the epigenetically regulated Avy allele in
Avy/a offspring (34, 35). These a/a offspring were housed
with same-sex Avy/a siblings to avoid physiological distur-
bances induced by singly housed animals. At 3, 6, and 9 mo of
age, energy expenditure, spontaneous activity, food intake,
and body composition measurements were completed on a/a
offspring at the Animal Phenotyping Core at the Michigan
Nutrition and Obesity Research Center (MNORC; Ann Ar-
bor, MI, USA). At the Animal Phenotyping Core, offspring
were singly housed and acclimated for a 7-d period in a 12-h
light-dark cycle. Proceeding the 7-d acclimation period, off-
spring were measured for energy expenditure (oxygen con-
sumption, oxygen consumption for lean body mass, and
carbon dioxide production) sequentially every 5 s in 20-min
intervals throughout a 72-h period using an open-circuit
indirect calorimeter [Comprehensive Lab Animal Monitoring
System (CLAMS), Columbus Instruments, Columbus, OH,
USA]. The respiratory exchange ratio was measured by taking
the ratio of carbon dioxide production and oxygen consump-
tion. Also during the 72-h period of testing, spontaneous
activity was measured in 3 axes, including ambulatory (walk-
ing), total horizontal (ambulatory plus additional horizontal
movement), and vertical dimensions. Motion was detected
every second in 20-min intervals using infrared (IR) photo-
beam technology, where the interruption of a single IR beam
tallied as a count. In addition, ad libitum food intake was
measured using powdered food and a precision scale in
20-min increments. After completion of the 72 h indirect
calorimetry testing, body composition was evaluated on con-
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scious mice through nuclear magnetic resonance (NMR;
Minispec LF90II; Bruker Optics, Billerica, MA, USA) imaging,
distinguishing fat tissue mass, lean tissue mass, and body
fluids. Body weight was measured before initiation of the
experiments at each life-course time point.
Hormone panel
Following the 72-h period of CLAMS at the 9-mo visit to the
MNORC, animals were unfed for a 5-h period and subse-
quently subjected to an oral glucose tolerance test (OGTT).
Each animal received a glucose dose of 2 g/kg BW via oral
gavage. Glucose and insulin levels were measured at baseline
and at 15, 30, 60, and 120 min via glucometer (Acucheck;
Roche, Indianapolis, IN, USA) and enzyme-linked immu-
nosorbent assay (ELISA; Millipore, St. Charles, MO, USA),
respectively. At 10 mo of age, the animals were euthanized.
Females were euthanized on the first day of estrus according
to vaginal cytology (36). Serum was collected by a hepatic vein
snip. Adiponectin and leptin serum levels were measured via
ELISA according to the manufacturer’s instructions.
Data analysis
Life-course energy expenditure, spontaneous activity, and food
intake were evaluated at 3, 6, and 9 mo of age over a 72-h (3-d)
period in 20-min intervals. Data were collapsed (averaged) to
light and dark cycles, and mixed linear regression models for
repeated measures, adjusted for sex and light cycles, were
estimated. Body composition was evaluated at the end of the
72-h assessment period at 3, 6, and 9 mo of age; a mixed linear
regression model was estimated, adjusting for sex. The mixed
linear regression models incorporated the correlation within
litters with a random intercept, and correlation among repeated
measures within individual mice using an autoregressive corre-
lation structure chosen using the maximum likelihood ratio test.
Models were evaluated with sex-exposure, time-exposure, and
sex-time-exposure interaction terms. As a sensitivity analyses,
separate models were run for each day of the 3-d assessment period
for energy expenditure, spontaneous activity, and food intake at all
ages (3, 6, and 9 mo of age) in order to determine differences in
effects across d 1 through d 3 of assessment. Hormone analyses
were completed by using a repeated-measures model accounting
for within-litter correlation. The homeostatic model assessment of
insulin resistance (HOMA-IR) was performed on fasting glucose
and insulin levels. Results were considered significant at values of
P0.05 and marginally significant at values ofP0.05 and0.10.
All statistical analyses were completed using SAS 9.2 software (SAS
Institutes, Cary, NC, USA).
RESULTS
As previously reported, dietary physiologically relevant
perinatal BPA exposure at 50 ng (n14 litters, 107 total
offspring), 50 g (n9 litters, 67 total offspring), or 50
mg (n13 litters, 91 total offspring) BPA/kg diet did
not significantly influence litter size (P0.44), survival
(P0.82), genotypic ratio (P0.46), or sex ratio (P0.16)
compared to control offspring (n11 litters, 86 total off-
spring) (31). BPA exposure was significantly associated with
lower wean weight of nanogram-exposed offspring (P0.03)
but not microgram- or milligram-exposed offspring (31).
For the analysis of physiological effects across the life
course at 3, 6, and 9 mo, we analyzed offspring exposed
to 50 ng (n20), 50 g (n21), or 50 mg (n18)
BPA/kg diet, as well as controls (n20). Due to non-
monotonic and/or nonlinear trends across the life
span within BPA dose groups, we report values for each
exposure group (nanogram, microgram, and milli-
grams) individually in comparison to the control group
at 3 time points across the life span. In addition, we
report the general (overall) significance of each out-
come across exposure groups over time.
Energy expenditure
Overall, oxygen consumption differs following perina-
tal dietary exposure to all levels of BPA across the life
course for females and males (P0.001 and P0.001,
respectively). Female offspring exposed to 50 ng BPA/kg
developed increased oxygen consumption at 6 and 9 mo
of age, with an average of 5156 and 4526 ml/kg/h
compared to an average of 3814 and 3749 ml/kg/h in
controls, respectively (P0.09 and P0.001, respec-
tively; Fig. 1A). Females exposed to 50 g BPA/kg had
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Figure 1. Energy expenditure (ml/kg/h) measured by indirect calorimetry over a 72-h period. Oxygen consumption (A) and
carbon dioxide production (B) across the life course, stratified by offspring sex. P values represent nanogram (n10 female, 10
male), microgram (n10 female, 11 male), or milligram (n9 female, 9 male) BPA-exposed offspring compared to control
offspring (n10 female, 10 male).
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an average oxygen consumption of 4556 and 4301
ml/kg/h vs. 4152 and 3814 ml/kg/h in the controls at
3 and 6 mo of age, respectively (P0.06 and P0.02,
respectively; Fig. 1A). Females exposed to 50 mg
BPA/kg had an average oxygen consumption of 4783
and 4584 vs. 4152 and 3814 ml/kg/h in the controls at
3 and 6 mo of age, respectively (P0.004 and P0.001,
respectively; Fig. 1A). At 9 mo of age, males had oxygen
consumption levels of 3713 and 3574 ml/kg/h when
exposed to 50 g or 50 mg BPA/kg, respectively,
compared to 3052 ml/kg/h in controls (P0.002 and
P0.02, respectively; Fig. 1A). In addition, oxygen
consumption corrected for lean body mass was mea-
sured to avoid bias from inactive fat mass (37). Overall,
oxygen consumption corrected for lean body mass was
significantly different across exposure groups over the
life span in females and males (P0.001 and P0.001,
respectively).
Carbon dioxide production was different across ex-
posure groups over the life course in females and males
(P0.001 and P0.001, respectively). Females exposed
to 50 ng BPA/kg had average carbon dioxide produc-
tion levels of 3897 and 3736 ml/kg/h at 6 and 9 mo of
age vs. 3487 and 3264 ml/kg/h in the controls, respec-
tively (P0.07 and P0.05, respectively; Fig. 1B). Fe-
males exposed to 50 g BPA/kg had average carbon
dioxide production of 3692 vs. 3264 ml/kg/h in con-
trols at 9 mo of age (P0.07; Fig. 1B). At 3 and 6 mo of
age, females exposed to 50 mg BPA/kg developed
average carbon dioxide production levels of 3652 and
4113 vs. 4057 and 3486 ml/kg/h in controls, respec-
tively (P0.10 and P0.009, respectively; Fig. 1B).
Males exposed to 50 g and mg BPA/kg developed an
average carbon dioxide production of 5858 and 4021
ml/kg/h at 3 mo of age, respectively, compared to 3391
ml/kg/h in controls (P0.04 and P0.008, respec-
tively; Fig. 1B). Respiratory exchange ratio was calcu-
lated to determine the source of energy metabolism
used by the exposed offspring in comparison to the
controls across different time points over the life
course. No significant differences were observed. In
addition, the control group displayed a natural decline
in energy expenditure throughout the life course (Fig.
1), as noted in previous work (38).
Spontaneous activity
Horizontal activity was different across the BPA dosages
over the life course in females but not in males (P0.07
and P0.58, respectively). Female offspring exposed
to 50 ng BPA/kg had an average horizontal activity of
2976 and 3067 counts/h at 3 and 9 mo of age.
compared to 2483 and 2591counts/h in controls, re-
spectively (P0.04 and P0.05, respectively; Fig. 2A).
At 9 mo of age, females exposed to 50 g or 50 mg
BPA/kg displayed an average horizontal activity of 3241
and 3447 counts/h, respectively, compared to 2591
counts/h in control offspring (P0.007 and P0.001,
respectively; Fig. 2A). Males exposed to 50 g or 50 mg
BPA/kg had an average of 2740 and 2906 counts/h in
horizontal activity, respectively, compared to 2196
counts/h in controls at 3 mo of age (P0.02 and
P0.003; Fig. 2A). Ambulatory activity (subset of total
horizontal activity) was not different over the life course
across the exposure groups in females, but the trend
was different in males (P0.36 and P0.001, respec-
tively). Females, however, did exhibit increases in am-
bulatory activity on exposure at individual assessment
points. For example, at 3 and 9 mo of age, females
exposed to 50 ng BPA/kg exhibited average ambula-
tory movement of 1740 and 1739 counts/h, compared
to 1281 and 1372 counts/h in controls, respectively,
(P0.01 and P0.05, respectively).
Vertical activity was different across the exposure
groups throughout the life course in females, but the
trend was not different in males over time (P0.06 and
P0.87, respectively). Females exposed to 50 ng BPA/kg
dietary exposure had average vertical activity of 1202
counts/h at 9 mo vs. 874 counts/h in controls (P0.07;
Fig. 2B). At 3, 6, and 9 mo of age, females in the
microgram-exposed group displayed average increase ver-
tical activity of 1086, 1312, and 1501 vs. 749, 987, and 874
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Figure 2. Spontaneous activity (counts/h) measured via IR photobeam detection average over a 72-h period. Horizontal (A) and
vertical (B) activity across the life course, stratified by offspring sex. P values represent nanogram (n10 female, 10 male),
microgram (n10 female, 11 male), or milligram (n9 female, 9 male) BPA-exposed offspring compared to control offspring
(n10 female, 10 male).
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counts/h displayed by controls, respectively (P0.06,
P0.06, and P0.001, respectively; Fig. 2B). At 3, 6, and 9
mo of age, females exposed to 50 mg BPA/kg displayed
average vertical activity of 1210, 1453, and 1379 vs. 749,
987, and 874 counts/h displayed by controls, respectively
(P0.01, P0.01, and P0.007, respectively; Fig. 2B).
Vertical activity in milligram-exposed males at 3 mo
of age was 1267 counts/h, compared to 750 counts/h
in controls (P0.004; Fig. 2B). In addition, the
control group displayed a natural decline in sponta-
neous activity levels throughout the life course (Fig.
2), as previously observed (39).
Food intake
Food intake was different over time across the exposure
groups in females and males (P0.04 and 0.10, respec-
tively). Females exposed to 50 ng BPA/kg had an average
food intake of 2.12 vs. 2.40 g in controls at 6 mo of age
(P0.05; Fig. 3). Females exposed to 50 g BPA/kg had
average intake of 2.04 and 2.08 g at 6 and 9 mo of age vs.
2.44 and 2.36 g in controls, respectively (P0.02 and
P0.10, respectively; Fig. 3). At 3 mo of age, the milli-
gram-exposed females had average intake of 2.15 vs.
2.56 g in the controls (P0.06; Fig. 3). At 9 mo of age,
nanogram- and microgram-exposed males exhibited aver-
age food intake of 2.90 and 2.34 g, respectively, vs. 2.63 g
in controls (P0.10 and P0.08, respectively; Fig. 3).
Day-to-day variability assessment
Energy expenditure, spontaneous activity, and food in-
take were measured over a 72-h period (3 d) at each age
of assessment (3, 6, and 9 mo). The mice underwent a 7-d
acclimation period prior to the onset of the 3-d pheno-
typic assessment, but a possibility of variability among
results remained from d 1 through 3 of testing. Thus,
each day was measured separately to determine whether a
particular day primarily contributed to differences be-
tween exposure and control groups. We found that dif-
ferences among exposure groups vs. the control group
remain statistically significant from d 1 through 3 of
testing. For example, milligram-exposed females had sig-
nificantly higher oxygen consumption at 6 mo of age on
d 1, 2, and 3 of phenotypic assessment (P0.02, P0.03,
and P0.005, respectively), and microgram-exposed fe-
males had significantly higher ambulatory activity at 3 mo
of age on d 1, 2, and 3 of phenotypic assessment (P0.02,
P0.001, and P0.001, respectively) compared to con-
trols. Due to homogeneous differences across the 3 d of
assessment, we choose to focus on the average measure-
ments across the total 3-d (72-h) period of testing at each
age of assessment, as reported above.
Body composition
Overall, body composition measures did not differ signif-
icantly over the life course across multiple BPA doses in
females and males (all P0.10), but significant differ-
ences occurred in particular exposure groups and time
points when compared to controls, especially in females.
At 6 and 9 mo of age, nanogram-exposed females dis-
played an average body weight of 27.2 and 28.4 vs. 30.9
and 32.1 g in controls, respectively (P0.05 and P0.06,
respectively; Fig. 4A). At 6 and 9 mo of age, nanogram-
exposed females had an average fat mass of 4.00 and 4.45
vs. 6.05 and 6.15 g in controls, respectively (P0.03 and
P0.08, respectively; Fig. 4B). At 3 mo of age, microgram-
exposed females had average body fat of 2.33 vs. 4.07 g in
control offspring (P0.06; Fig. 4B). At 6 mo of age,
milligram-exposed females had average body fat of 4.50
vs. 6.05 g in controls (P0.08; Fig. 4B). No significant
changes were found in fat mass in males (Fig. 4B) or in
lean body mass in all offspring across the life span.
Hormone panel
The mean baseline glucose and insulin levels in milli-
gram-exposed females were lower compared to controls
(P0.05 and P0.10, respectively; Fig. 5A). HOMA-IR
was conducted to capture insulin sensitivity among the
exposure groups. The milligram-exposed females dis-
played a HOMA index of 3.02 vs. 8.12 for the control
females (P0.10; Fig. 5C). The mean adiponectin levels
in nanogram- and milligram-exposed females were 57.3
and 47 g/ml, respectively, compared to 31.1 g/ml in
controls (P0.02 and P0.10, respectively; Fig. 5D).
Alternatively, males exposed to 50 g BPA/kg had
marginally significant lower levels of adiponectin
(P0.06; Fig. 5D). Serum leptin levels in milligram-
exposed females were 11.1 ng/ml compared to female
control serum levels of 18 ng/ml (P0.10; Fig. 5E).
DISCUSSION
Offspring exposed to 50 ng, 50 g, and 50 mg of
BPA/kg of diet during gestation and lactation devel-
oped an overall increase in energy expenditure
throughout their life course, measured via indirect
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Figure 3. Food intake (g) across the life course, measured by
powdered food on a precision scale over a 72-h period,
stratified by offspring sex. P values represent nanogram
(n10 female, 10 male), microgram (n10 female, 11 male),
or milligram (n9 female, 9 male) BPA-exposed offspring
compared to control offspring (n10 female, 10 male).
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calorimetry in comparison to unexposed control off-
spring across a 72-h period. Limited studies explore in
utero environmental exposures, especially BPA, and
their effect on oxygen consumption and carbon diox-
ide production. McKenzie et al. (40) explored heavy
metal and organic compound (PAH, PCB, and OCP)
exposure on the metabolic rate of adult fish in different
geographical species and reported that exposed cyprinid
fish in The Netherlands developed an increased resting
metabolic rate. In contrast to the increased energy expen-
diture observed in our perinatal BPA exposure offspring
cohort, adult short-term BPA exposure to 100 g/kg BW
via injection in mice resulted in decreased energy expen-
diture, indicating that timing, duration, and route of BPA
exposure may have differing effects on metabolic end-
points (41).
Corresponding to the observed increase in energy
expenditure in the current study, spontaneous activity
levels were increased in offspring following perinatal
BPA exposure, with outcomes more prominent among
females. The hyperactive phenotype found in animal
models is analogous to human clinical disorders like
ADHD and aggression (42). Multiple animal models
have been used to assess early life exposure to BPA and
its effect on activity and behavior-related outcomes. In
mice, a single oral dose of 0.32, 3.2, or 4.8 mg BPA/kg
BW at PND 10 initiated hyperactivity in males as adults
(43). In 3-wk-old male rats exposed to a maternal diet of
2 g BPA/kg BW from GD 7 to PND 10, Zhou et al. (26)
reported increased activity and discovered corresponding
alterations to the dopaminergic system, which is a known
target in disorders like ADHD (44). Zebrafish larvae
exposed to 0.01 and 0.1, M of BPA for 48 h during
postfertilization revealed hyperactivity as adults com-
pared to unexposed controls (45). Furthermore, hu-
man epidemiological evidence noted positive relation-
ships among maternal gestational urinary BPA levels
and hyperactivity and aggression in children, especially
in females (24, 28).
In this present study, sophisticated NMR body compo-
sition analysis revealed marginally significant changes in
body weight and fat mass. In a previous report, female and
male rats exposed to 2.5 or 5 g BPA/kg BW/d from GD
6 through PND 21 had significantly lower body weights
compared to controls from PND 0 to 21 (46). Using
repeated body weight measurements, CD-1 mice ex-
posed to dietary BPA during gestation and lactation
were heavier than controls at 4 wk of age, but this
association was diminished in adulthood, and the effect
did not persist in offspring fed a high-fat diet (47).
Alternatively, Wei et al. (48) looked at perinatal expo-
sure to several doses of BPA by oral gavage in rats. As
adults, offspring developed increased body weight
when exposed to 50 g/kg perinatally, which was
exacerbated when offspring were fed a high-fat diet.
Female offspring exposed to 70 g BPA/kg BW/d via
maternal drinking water from GD 6 through lactation
displayed increased body weight on weaning, with a
corresponding increase in white adipose tissue and
expression of lipogenic genes (18).
With much attention focused on body weight and
composition after early life BPA exposure, researchers
have developed a natural concern of BPA’s influence
on insulin sensitivity and glucose tolerance as metabolic
endpoints. Within this study, our fasting glucose and
insulin tolerance test revealed an increase in insulin
sensitivity, with further validation using the HOMA-IR
index in females treated with 50 mg BPA/kg diet in
utero and through lactation. Conflicting evidence has
emerged in the literature indicating that BPA exposure
in early development induces early signs of type 2
diabetes and metabolic syndrome such as glucose intol-
erance and insulin resistance (49). For instance, male
rat offspring from dams fed a BPA-supplemented diet
during gestation exhibited glucose intolerance and
insulin insensitivity at 6 mo of age (17). Adult female
and male rats exposed to BPA in utero displayed altered
glucose and insulin homeostasis, which was exacer-
bated in males fed a high-fat diet (48).
We found that exposure to 50 ng and 50 mg of
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BPA/kg diet increased serum adiponectin levels in
female adult offspring. Adiponectin enhances insulin
responsiveness and glucose uptake, is mainly produced
by adipose tissue, and is negatively correlated with fat
mass in humans (50). Previous reports have shown that
BPA inhibits the release of adiponectin from human
adipose tissue, which suggests that BPA may promote
the development of insulin resistance (51). Interest-
ingly, the elevated levels of adiponectin in our study
were seen concurrently with increased spontaneous
activity and reduced fat mass in nanogram- and milli-
gram-exposed female offspring, and reduced insulin
and HOMA-IR in milligram-exposed female offspring
with modestly lower levels of glucose during an OGTT.
Thus, our data suggest that perinatal exposure to BPA
elevates adiponectin, and this may have occurred as a
consequence to hyperactivity and reduced body fat. Of
note, significant effects on these endpoints were not
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observed in the microgram-dose group, indicating pos-
sible nonmonotonic effects of perinatal BPA exposure,
an area of active interest and investigation (31, 52, 53).
We report significantly decreased serum leptin fol-
lowing exposure to 50 mg BPA among females and
modestly lower (nonsignificant) leptin levels among
microgram- and nanogram-, and microgram- and mil-
ligram-exposed females and males, respectively. Leptin
is a hormone produced by adipose tissue that is posi-
tively correlated with body fat mass and plays a key role
in energy homeostasis (50). There are limited in vivo
studies on leptin following BPA exposure. Briefly, one
study has shown that perinatal BPA exposure resulted
in increased serum leptin levels in both females and
males on both a high-fat and normal-fat diet, which was
positively associated with body fat (48). In another
report, serum leptin levels at PND 21 were unchanged
vs. controls in rats exposed to 2.5 or 5 g BPA/kg
BW/d perinatally (46). In contrast to previous reports,
our data propose that decreased leptin levels are cor-
related with reduced body fat following perinatal BPA
exposure.
Alterations in metabolic phenotypes in BPA exposed
offspring were more prominent in females than males,
within the current study. Other literature describes
early life BPA exposure resulting in gender specific
outcomes as well (24). Early life BPA exposure can
affect sexually dimorphic traits in vivo when normal
circulating levels of androgens are needed during brain
development to shape sexually distinct behaviors (42,
54, 55). Variable outcomes across studies highlighted
throughout this discussion may be attributable to non-
standardized dietary fat and/or phytoestrogen content
and/or inconsistent use of sophisticated measurements
of body composition and energy expenditure con-
ducted at multiple time-points across the life course. Of
note, our exposure paradigm included a phytoestro-
gen-free and non-high-fat background diet. Future
studies are needed to evaluate whether diet modifies
the effects of perinatal BPA exposure on metabolic and
hormonal parameters throughout the life course. Stud-
ies will need to continue to focus on timing of expo-
sure, dose levels (particularly doses relevant to human
exposure), and differences among strains and species
in order to elucidate the complete phenotypic depic-
tion of early life BPA exposure on the development of
adult disease. In addition, the affected biological path-
ways will need to be determined, for example, by
evaluating epigenome-wide methylation and chromatin
profiles, in order to understand the mechanism linking
early BPA exposure to later disease risk.
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